These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1701393)

  • 1. [Allosteric receptor modulators--a new model for designing drugs].
    Komissarov IV
    Farmakol Toksikol; 1990; 53(5):3-7. PubMed ID: 1701393
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric modulation of ligand-gated ion channels.
    Hogg RC; Buisson B; Bertrand D
    Biochem Pharmacol; 2005 Nov; 70(9):1267-76. PubMed ID: 16043127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ion channels of neuronal electro- and chemoexcitable membranes as the targets psychopharmacological drug action].
    Abramets II
    Farmakol Toksikol; 1983; 46(6):99-105. PubMed ID: 6140187
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors.
    Im HK; Im WB; Judge TM; Gammill RB; Hamilton BJ; Carter DB; Pregenzer JF
    Mol Pharmacol; 1993 Aug; 44(2):468-72. PubMed ID: 8018215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of toxins and drugs as tools to study excitable membrane ion channels: II. Transmitter-activated channels.
    Narahashi T
    Methods Enzymol; 1992; 207():643-58. PubMed ID: 1382205
    [No Abstract]   [Full Text] [Related]  

  • 7. Excitatory amino acid antagonists as well as GABA agonists cause barbiturate-like anesthesia in rats.
    Richter JA; Gatto SL
    NIDA Res Monogr; 1989; 95():534-5. PubMed ID: 2561851
    [No Abstract]   [Full Text] [Related]  

  • 8. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modeling of hormonal receptors. Application to drug design].
    Hibert MF; Trumpp-Kallmeyer S; Bruinvels AT; Hoflack J
    Therapie; 1991; 46(6):445-51. PubMed ID: 1668042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor.
    McGurk KA; Pistis M; Belelli D; Hope AG; Lambert JJ
    Br J Pharmacol; 1998 May; 124(1):13-20. PubMed ID: 9630337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of receptors in the action of antiepileptic drugs.
    Airaksinen MM
    Acta Neurol Scand Suppl; 1983; 93():31-46. PubMed ID: 6132515
    [No Abstract]   [Full Text] [Related]  

  • 14. Markov modeling of allosteric drug effects on ion channels, with particular reference to neuronal nicotinic acetylcholine receptors.
    Madsen BW; Yeo GF
    Arch Biochem Biophys; 2000 Jan; 373(2):429-34. PubMed ID: 10620368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The endogenous allosteric regulators of receptors].
    Balashov AM
    Usp Fiziol Nauk; 2004; 35(2):73-91. PubMed ID: 15174297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-gated channel: postsynaptic receptors and drug targets.
    Jackson MB
    Adv Neurol; 1999; 79():511-24. PubMed ID: 10514839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
    Krishek BJ; Moss SJ; Smart TG
    Mol Pharmacol; 1996 Mar; 49(3):494-504. PubMed ID: 8643089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
    Szabo ST; Blier P
    Synapse; 2001 Dec; 42(4):203-12. PubMed ID: 11746719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.